Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47FU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,440
Award facts
- Contract value 100% obligated
- $23,440.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23.4K delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. The contract, which is a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999 through December 2026, which enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company competes on a full and open basis for federal contracts and maintains demonstrated capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains. This delivery order for Dupixent, a specialty biologic medication used in the treatment of eczema and other inflammatory conditions, aligns with the Defense Logistics Agency's mission to support military healthcare systems and the Defense Health Agency's medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F47FU?
SPE2DR26F47FU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F47FU worth?
The government has obligated $23,440 on SPE2DR26F47FU.
Is contract SPE2DR26F47FU an order under another contract?
Yes. SPE2DR26F47FU is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47FU competed?
The extent of competition for SPE2DR26F47FU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award